secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001104659-24-029361
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio regains Nasdaq minimum bid price compliance
-------------------------------------------------------

- Received notice from Nasdaq on Feb 29, 2024 confirming compliance with Listing Rule 5450(a)(1).
- Closing bid price of common stock was at least $1.00 for 10 consecutive business days through Feb 28.
- Previously disclosed deficiency notice on Aug 31, 2023 for bid price below $1.00 for 30 days.
- Listing matter is now closed; company meets all other continued listing criteria.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465924029361/0001104659-24-029361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465924029361/tm247492d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-029361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer